As a probiotic target for type 2 diabetes treatment, A. muciniphila stimulates incretin hormone secretion (glucagon-like peptide 1 (GLP-1), glucagon-like peptide 2 (GLP-2), and peptide YY (PYY))47. Here, PYY is linked to type 2 diabetes mellitus.